FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016303761> ?p ?o ?g. }

• W2016303761 endingPage "1022" @default.
• W2016303761 startingPage "1014" @default.
• W2016303761 abstract "Introduction Patients with systemic lupus erythematosus (SLE) have increased cardiovascular risk related to lipid changes induced by inflammatory activity, proteinuria and treatments. Our objective was to analyse lipid changes in a cohort of patients with SLE resistant to standard treatments who were treated with rituximab. Methods The study population comprised a retrospective multicentre, national cohort of patients with SLE resistant to standard treatments who were treated with rituximab. The basic lipid profile, concomitant treatment and disease activity were analysed at the start of the treatment, 24 weeks later, and at the end of the follow-up period. The effects of the main lupus variables and therapy on the lipid changes were analysed. Results Seventy-nine patients with active lupus treated with rituximab were assessed during 149.3 patient-years. Prior to the treatment, 69% had dyslipidaemia. The most frequent abnormalities were a low-density lipoprotein (LDL) level of ≥100 mg/dl (34%) and a high-density lipoprotein (HDL) level of <50 mg/dl (27%). Baseline total cholesterol (TC) and LDL levels correlated with the degree of proteinuria, while the concentration of triglycerides (TGs) correlated with the SLE Disease Activity Index (SLEDAI). TGs were reduced at short- and long-term follow-up after rituximab treatment. A multiple linear regression analysis identified that the reduction of the lupus inflammatory activity, particularly changes in proteinuria, was the only independent variable that was positively associated with the reduction in TGs after 24 weeks ( p = 0.001) and with TC ( p = 0.005) and TGs ( p < 0.001) at the end of the follow-up period. Conclusion Our results suggest that rituximab may improve the long-term lipid profile of patients with SLE refractory to standard treatment, mainly by reducing inflammatory activity." @default.
• W2016303761 created "2016-06-24" @default.
• W2016303761 creator A5013324467 @default.
• W2016303761 creator A5013412025 @default.
• W2016303761 creator A5033857149 @default.
• W2016303761 creator A5034211653 @default.
• W2016303761 creator A5036618124 @default.
• W2016303761 creator A5052029203 @default.
• W2016303761 creator A5052639342 @default.
• W2016303761 creator A5057658897 @default.
• W2016303761 creator A5069117824 @default.
• W2016303761 creator A5074639733 @default.
• W2016303761 creator A5075801510 @default.
• W2016303761 creator A5076189703 @default.
• W2016303761 creator A5080132056 @default.
• W2016303761 creator A5082120058 @default.
• W2016303761 creator A5085949462 @default.
• W2016303761 creator A5087919662 @default.
• W2016303761 date "2014-05-15" @default.
• W2016303761 modified "2023-10-16" @default.
• W2016303761 title "The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB)" @default.
• W2016303761 cites W1485976886 @default.
• W2016303761 cites W1525177589 @default.
• W2016303761 cites W1550700919 @default.
• W2016303761 cites W1557458006 @default.
• W2016303761 cites W1967977017 @default.
• W2016303761 cites W1976525661 @default.
• W2016303761 cites W1978259263 @default.
• W2016303761 cites W1988829041 @default.
• W2016303761 cites W2000445173 @default.
• W2016303761 cites W2001641494 @default.
• W2016303761 cites W2004556731 @default.
• W2016303761 cites W2010675961 @default.
• W2016303761 cites W2020182807 @default.
• W2016303761 cites W2021741488 @default.
• W2016303761 cites W2047634083 @default.
• W2016303761 cites W2064213999 @default.
• W2016303761 cites W2065219238 @default.
• W2016303761 cites W2089016290 @default.
• W2016303761 cites W2093880435 @default.
• W2016303761 cites W2098824980 @default.
• W2016303761 cites W2100976814 @default.
• W2016303761 cites W2108905161 @default.
• W2016303761 cites W2108943731 @default.
• W2016303761 cites W2115669319 @default.
• W2016303761 cites W2131999276 @default.
• W2016303761 cites W2146340417 @default.
• W2016303761 cites W2165779517 @default.
• W2016303761 cites W2165884492 @default.
• W2016303761 cites W2170874916 @default.
• W2016303761 cites W2396160532 @default.
• W2016303761 doi "https://doi.org/10.1177/0961203314534909" @default.
• W2016303761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24833667" @default.
• W2016303761 hasPublicationYear "2014" @default.
• W2016303761 type Work @default.
• W2016303761 sameAs 2016303761 @default.
• W2016303761 citedByCount "10" @default.
• W2016303761 countsByYear W20163037612015 @default.
• W2016303761 countsByYear W20163037612016 @default.
• W2016303761 countsByYear W20163037612017 @default.
• W2016303761 countsByYear W20163037612020 @default.
• W2016303761 countsByYear W20163037612021 @default.
• W2016303761 countsByYear W20163037612022 @default.
• W2016303761 countsByYear W20163037612023 @default.
• W2016303761 crossrefType "journal-article" @default.
• W2016303761 hasAuthorship W2016303761A5013324467 @default.
• W2016303761 hasAuthorship W2016303761A5013412025 @default.
• W2016303761 hasAuthorship W2016303761A5033857149 @default.
• W2016303761 hasAuthorship W2016303761A5034211653 @default.
• W2016303761 hasAuthorship W2016303761A5036618124 @default.
• W2016303761 hasAuthorship W2016303761A5052029203 @default.
• W2016303761 hasAuthorship W2016303761A5052639342 @default.
• W2016303761 hasAuthorship W2016303761A5057658897 @default.
• W2016303761 hasAuthorship W2016303761A5069117824 @default.
• W2016303761 hasAuthorship W2016303761A5074639733 @default.
• W2016303761 hasAuthorship W2016303761A5075801510 @default.
• W2016303761 hasAuthorship W2016303761A5076189703 @default.
• W2016303761 hasAuthorship W2016303761A5080132056 @default.
• W2016303761 hasAuthorship W2016303761A5082120058 @default.
• W2016303761 hasAuthorship W2016303761A5085949462 @default.
• W2016303761 hasAuthorship W2016303761A5087919662 @default.
• W2016303761 hasConcept C126322002 @default.
• W2016303761 hasConcept C203014093 @default.
• W2016303761 hasConcept C2776912625 @default.
• W2016303761 hasConcept C2778163477 @default.
• W2016303761 hasConcept C2778270857 @default.
• W2016303761 hasConcept C2779134260 @default.
• W2016303761 hasConcept C2779338263 @default.
• W2016303761 hasConcept C2779384505 @default.
• W2016303761 hasConcept C2779561371 @default.
• W2016303761 hasConcept C2780091579 @default.
• W2016303761 hasConcept C2780653079 @default.
• W2016303761 hasConcept C2908647359 @default.
• W2016303761 hasConcept C71924100 @default.
• W2016303761 hasConcept C72563966 @default.
• W2016303761 hasConcept C90924648 @default.
• W2016303761 hasConcept C99454951 @default.
• W2016303761 hasConceptScore W2016303761C126322002 @default.

• next